Announcements
Trials
Browse
Landscape
Eligibility
Clinical Trials
1 trials
Recent
Start date
Enrollment
Completed
×
INDUSTRY
×
G250 monoclonal antibody
×
Clear all
Filters
3
NCT00087022
2018-11-27
ARISER
Heidelberg Pharma AG
Phase 3
Completed
864 enrolled
10 charts